| Product Code: ETC8049338 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The import shipments of pregabalin into Lithuania in 2024 continued to show strong growth, with top exporting countries being China, Netherlands, Germany, Spain, and Poland. The market remained highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 20.42%, with a notable growth spurt of 119.1% from 2023 to 2024. This data suggests a thriving market for pregabalin in Lithuania, driven by consistent demand and diverse sources of import.
| 1 Executive Summary | 
| 2 Introduction | 
| 2.1 Key Highlights of the Report | 
| 2.2 Report Description | 
| 2.3 Market Scope & Segmentation | 
| 2.4 Research Methodology | 
| 2.5 Assumptions | 
| 3 Lithuania Pregabalin Market Overview | 
| 3.1 Lithuania Country Macro Economic Indicators | 
| 3.2 Lithuania Pregabalin Market Revenues & Volume, 2021 & 2031F | 
| 3.3 Lithuania Pregabalin Market - Industry Life Cycle | 
| 3.4 Lithuania Pregabalin Market - Porter's Five Forces | 
| 3.5 Lithuania Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F | 
| 3.6 Lithuania Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F | 
| 3.7 Lithuania Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F | 
| 4 Lithuania Pregabalin Market Dynamics | 
| 4.1 Impact Analysis | 
| 4.2 Market Drivers | 
| 4.2.1 Increasing prevalence of neurological disorders in Lithuania | 
| 4.2.2 Growing awareness about the effectiveness of pregabalin in managing neuropathic pain | 
| 4.2.3 Rising geriatric population in Lithuania requiring treatment for chronic pain | 
| 4.3 Market Restraints | 
| 4.3.1 Stringent regulations and approval process for pharmaceutical products in Lithuania | 
| 4.3.2 Competition from alternative pain management therapies in the market | 
| 5 Lithuania Pregabalin Market Trends | 
| 6 Lithuania Pregabalin Market, By Types | 
| 6.1 Lithuania Pregabalin Market, By Application | 
| 6.1.1 Overview and Analysis | 
| 6.1.2 Lithuania Pregabalin Market Revenues & Volume, By Application, 2021- 2031F | 
| 6.1.3 Lithuania Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F | 
| 6.1.4 Lithuania Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F | 
| 6.1.5 Lithuania Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F | 
| 6.1.6 Lithuania Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.2 Lithuania Pregabalin Market, By Drug Class | 
| 6.2.1 Overview and Analysis | 
| 6.2.2 Lithuania Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F | 
| 6.2.3 Lithuania Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F | 
| 6.2.4 Lithuania Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 6.3 Lithuania Pregabalin Market, By Distribution Channel | 
| 6.3.1 Overview and Analysis | 
| 6.3.2 Lithuania Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F | 
| 6.3.3 Lithuania Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F | 
| 6.3.4 Lithuania Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F | 
| 6.3.5 Lithuania Pregabalin Market Revenues & Volume, By Others, 2021- 2031F | 
| 7 Lithuania Pregabalin Market Import-Export Trade Statistics | 
| 7.1 Lithuania Pregabalin Market Export to Major Countries | 
| 7.2 Lithuania Pregabalin Market Imports from Major Countries | 
| 8 Lithuania Pregabalin Market Key Performance Indicators | 
| 8.1 Prescription rate of pregabalin by healthcare providers in Lithuania | 
| 8.2 Patient adherence and compliance rate to pregabalin treatment | 
| 8.3 Number of clinical trials and research studies conducted on pregabalin efficacy in Lithuania | 
| 9 Lithuania Pregabalin Market - Opportunity Assessment | 
| 9.1 Lithuania Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F | 
| 9.2 Lithuania Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F | 
| 9.3 Lithuania Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F | 
| 10 Lithuania Pregabalin Market - Competitive Landscape | 
| 10.1 Lithuania Pregabalin Market Revenue Share, By Companies, 2024 | 
| 10.2 Lithuania Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters | 
| 11 Company Profiles | 
| 12 Recommendations | 
| 13 Disclaimer |